Диссертация (1145980), страница 19
Текст из файла (страница 19)
— P. 60-67.72.Halaby T., Reuland A. E., Al Naiemi N., Potron A., Savelkoul P. H.,Vandenbroucke-Grauls C. M., Nordmann P. A case of New Delhimetallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniaewith putative secondary transmission from the Balkan region in theNetherlands // Antimicrob Agents Chemother. — 2012.
— V. 56, № 5.— P. 2790-2791.73.Hopkins J. M., Towner K. J. Enhanced resistance to cefotaxime andimipenem associated with outer membrane protein alterations inEnterobacter aerogenes // J Antimicrob Chemother. — 1990. — V. 25, №1. — P. 49-55.12174.Hrabak J., Walkova R., Studentova V., Chudackova E., Bergerova T.Carbapenemase activity detection by matrix-assisted laser desorptionionization-time of flight mass spectrometry // J Clin Microbiol. — 2011.— V. 49, № 9. — P. 3222-3227.75.Iseman M. D. Treatment of multidrug-resistant tuberculosis // N Engl JMed. — 1993.
— V. 329, № 11. — P. 784-791.76.Jacoby G. A. AmpC beta-lactamases // Clin Microbiol Rev. — 2009. —V. 22, № 1. — P. 161-182.77.Jovcic B., Lepsanovic Z., Suljagic V., Rackov G., Begovic J., TopisirovicL., Kojic M. Emergence of NDM-1 metallo-beta-lactamase inPseudomonas aeruginosa clinical isolates from Serbia // AntimicrobAgents Chemother. — 2011. — V. 55, № 8.
— P. 3929-39231.78.Kim M. N., Yong D., An D., Chung H. S., Woo J. H., Lee K., Chong Y.Nosocomial clustering of NDM-1-producing Klebsiella pneumoniaesequence type 340 strains in four patients at a South Korean tertiary carehospital // J Clin Microbiol. — 2012. — V. 50, № 4. — P. 1433-1436.79.Kitchel B., Rasheed J. K., Patel J. B., Srinivasan A., Navon-Venezia S.,Carmeli Y., Brolund A., Giske C. G. Molecular epidemiology of KPCproducing Klebsiella pneumoniae isolates in the United States: clonalexpansion of multilocus sequence type 258 // Antimicrob AgentsChemother.
— 2009. — V. 53, № 8. — P. 3365-3370.80.Koh T. H., Cao D., Shan Q. Y., Bacon A., Hsu L. Y., Ooi E. E. Acquiredcarbapenemases in Enterobactericeae in Singapore, 1996-2012 //Pathology. — 2013. — V. 45, № 6. — P. 600-603.81.Ktari S., Arlet G., Mnif B., Gautier V., Mahjoubi F., Ben Jmeaa M.,Bouaziz M., Hammami A.
Emergence of multidrug-resistant Klebsiellapneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamasein a Tunisian university hospital // Antimicrob Agents Chemother. —2006. — V. 50, № 12. — P. 4198-4201.12282.Kumarasamy K. K., et al.
Emergence of a new antibiotic resistancemechanism in India, Pakistan, and the UK: a molecular, biological, andepidemiological study // Lancet Infect Dis. — 2010. — V. 10, № 9. — P.597-602.83.Laible G., Spratt B. G., Hakenbeck R. Interspecies recombinationalevents during the evolution of altered PBP 2x genes in penicillin-resistantclinical isolates of Streptococcus pneumoniae // Mol Microbiol. — 1991.— V. 5, № 8. — P. 1993-2002.84.Landman D., Salvani J. K., Bratu S., Quale J. Evaluation of techniquesfor detection of carbapenem-resistant Klebsiella pneumoniae in stoolsurveillance cultures // J Clin Microbiol. — 2005. — V.
43, № 11. — P.5639-5641.85.Laraki N., Franceschini N., Rossolini G. M., Santucci P., Meunier C., dePauw E., Amicosante G., Frere J. M., Galleni M. Biochemicalcharacterization of the Pseudomonas aeruginosa 101/1477 metallo-betalactamase IMP-1 produced by Escherichia coli // Antimicrob AgentsChemother. — 1999.
— V. 43, № 4. — P. 902-906.86.Lauretti L., Riccio M. L., Mazzariol A., Cornaglia G., Amicosante G.,Fontana R., Rossolini G. M. Cloning and characterization of blaVIM, anew integron-borne metallo-beta-lactamase gene from a Pseudomonasaeruginosa clinical isolate // Antimicrob Agents Chemother. — 1999. —V. 43, № 7. — P. 1584-1590.87.Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M.
J., CarmeliY. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiellapneumoniae strains in an Israeli hospital // Antimicrob AgentsChemother. — 2007. — V. 51, № 8. — P. 3026-3029.88.Lee J., Patel G., Huprikar S., Calfee D. P., Jenkins S. G. Decreasedsusceptibility to polymyxin B during treatment for carbapenem-resistantKlebsiella pneumoniae infection // J Clin Microbiol.
— 2009. — V. 47,№ 5. — P. 1611-1612.12389.Lee K., Lee W. G., Uh Y., Ha G. Y., Cho J., Chong Y., KoreanNationwide Surveillance of Antimicrobial Resistance G. VIM- and IMPtypemetallo-beta-lactamase-producingPseudomonasspp.andAcinetobacter spp. in Korean hospitals // Emerg Infect Dis.
— 2003. —V. 9, № 7. — P. 868-871.90.Levy S. B. Microbial resistance to antibiotics. An evolving and persistentproblem // Lancet. — 1982. — V. 2, № 8289. — P. 83-88.91.Levy S. B., McMurry L. M., Barbosa T. M., Burdett V., Courvalin P.,Hillen W., Roberts M. C., Rood J. I., Taylor D. E. Nomenclature for newtetracycline resistance determinants // Antimicrob Agents Chemother. —1999. — V. 43, № 6. — P. 1523-4.92.Li G., Wei Q., Wang Y., Du X., Zhao Y., Jiang X. Novel geneticenvironment of the plasmid-mediated KPC-3 gene detected inEscherichia coli and Citrobacter freundii isolates from China // Eur J ClinMicrobiol Infect Dis. — 2011. — V. 30, № 4.
— P. 575-580.93.Livermore D. M., Walsh T. R., Toleman M., Woodford N. Balkan NDM1: escape or transplant? // Lancet Infect Dis. — 2011. — V. 11, № 3. —P. 164.94.Livermore D. M., Woodford N. Carbapenemases: a problem in waiting?// Curr Opin Microbiol. — 2000. — V. 3, № 5. — P. 489-495.95.Lupo A., Coyne S., Berendonk T. U. Origin and evolution of antibioticresistance: the common mechanisms of emergence and spread in waterbodies // Front Microbiol. — 2012.
— V. 3. — P. 18.96.Luzzaro F., Docquier J. D., Colinon C., Endimiani A., Lombardi G.,Amicosante G., Rossolini G. M., Toniolo A. Emergence in Klebsiellapneumoniae and Enterobacter cloacae clinical isolates of the VIM-4metallo-beta-lactamase encoded by a conjugative plasmid // AntimicrobAgents Chemother. — 2004. — V. 48, № 2. — P. 648-650.97.Marcano D., Pasteran F., Rapoport M., Faccone D., Ugarte C., SalgadoN., Payares D., Spadola E., Lopez Y., Maggi G., Galas M., Sanchez D.124First isolation of a VIM-producing Klebsiella pneumoniae from a sevenyear-old child in Venezuela // J Infect Dev Ctries.
— 2008. — V. 2, № 3.— C. 241-244.98.Marchiaro P., Ballerini V., Spalding T., Cera G., Mussi M. A., MoranBarrio J., Vila A. J., Viale A. M., Limansky A. S. A convenientmicrobiological assay employing cell-free extracts for the rapidcharacterization of Gram-negative carbapenemase producers // JAntimicrob Chemother.
— 2008. — V. 62, № 2. — P. 336-344.99.Martinez-Martinez L., Pascual A., Jacoby G. A. Quinolone resistancefrom a transferable plasmid // Lancet. — 1998. — V. 351, № 9105. — P.797-9.100. Massova I., Mobashery S. Kinship and diversification of bacterialpenicillin-binding proteins and beta-lactamases // Antimicrob AgentsChemother. — 1998. — V. 42, № 1. — P. 1-17.101. Matthew M. Plasmid-mediated beta-lactamases of Gram-negativebacteria: properties and distribution // J Antimicrob Chemother.
— 1979.— V. 5, № 4. — P. 349-358.102. Mavroidi A., Miriagou V., Malli E., Stefos A., Dalekos G. N.,Tzouvelekis L. S., Petinaki E. Emergence of Escherichia coli sequencetype 410 (ST410) with KPC-2 beta-lactamase // Int J Antimicrob Agents.— 2012. — V. 39, № 3. — P. 247-250.103. Mercuri P. S., Ishii Y., Ma L., Rossolini G. M., Luzzaro F., AmicosanteG., Franceschini N., Frere J.
M., Galleni M. Clonal diversity and metallobeta-lactamase production in clinical isolates of Stenotrophomonasmaltophilia // Microb Drug Resist. — 2002. — V. 8, № 3. — P. 193-200.104. Meroueh S. O., Fisher J. F., Schlegel H. B., Mobashery S. Ab initioQM/MM study of class A beta-lactamase acylation: dual participation ofGlu166 and Lys73 in a concerted base promotion of Ser70 // J Am ChemSoc.
— 2005. — V. 127, № 44. — P. 15397-153407.125105. Minasov G., Wang X., Shoichet B. K. An ultrahigh resolution structureof TEM-1 beta-lactamase suggests a role for Glu166 as the general basein acylation // J Am Chem Soc. — 2002. — V. 124, № 19. — P. 53335340.106. Munoz-Price L. S., Poirel L., Bonomo R. A., Schwaber M. J., Daikos G.L., Cormican M., Cornaglia G., Garau J., Gniadkowski M., Hayden M.K., Kumarasamy K., Livermore D. M., Maya J.
J., Nordmann P., Patel J.B., Paterson D. L., Pitout J., Villegas M. V., Wang H., Woodford N.,Quinn J. P. Clinical epidemiology of the global expansion of Klebsiellapneumoniae carbapenemases // Lancet Infect Dis. — 2013. — V. 13, №9. — P. 785-796.107. Mussi M. A., Limansky A. S., Viale A. M. Acquisition of resistance tocarbapenems in multidrug-resistant clinical strains of Acinetobacterbaumannii: natural insertional inactivation of a gene encoding a memberof a novel family of beta-barrel outer membrane proteins // AntimicrobAgents Chemother. — 2005.
— V. 49, № 4. — P. 1432-1440.108. Naas T., Cuzon G., Truong H. V., Nordmann P. Role of ISKpn7 anddeletions in blaKPC gene expression // Antimicrob Agents Chemother.— 2012. — V. 56, № 9. — P. 4753-4759.109. Naas T., Cuzon G., Villegas M. V., Lartigue M. F., Quinn J. P.,Nordmann P. Genetic structures at the origin of acquisition of the betalactamase bla KPC gene // Antimicrob Agents Chemother. — 2008. —V. 52, № 4.
— P. 1257-1263.110. Naas T., Nordmann P. Analysis of a carbapenem-hydrolyzing class Abeta-lactamase from Enterobacter cloacae and of its LysR-type regulatoryprotein // Proc Natl Acad Sci U S A. — 1994. —V. 91, № 16. — P.7693-7697.111. Naas T., Nordmann P., Vedel G., Poyart C. Plasmid-mediatedcarbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae126isolate from France // Antimicrob Agents Chemother.
— 2005. — V. 49,№ 10. — P. 4423-4424.112. Nikaido H. Multidrug efflux pumps of gram-negative bacteria // JBacteriol. — 1996. — V. 178, № 20. — P. 5853-9.113. Nordmann P., Boulanger A. E., Poirel L. NDM-4 metallo-beta-lactamasewith increased carbapenemase activity from Escherichia coli //Antimicrob Agents Chemother. — 2012. — V. 56, № 4. — P. 21842186.114. Nordmann P., Naas T., Poirel L. Global spread of Carbapenemaseproducing Enterobacteriaceae // Emerg Infect Dis. — 2011. — V. 17, №10. — P. 1791-1798.115.
Nordmann P., Poirel L., Toleman M. A., Walsh T. R. Does broadspectrum beta-lactam resistance due to NDM-1 herald the end of theantibiotic era for treatment of infections caused by Gram-negativebacteria? // J Antimicrob Chemother. — 2011. — V. 66, № 4. — P. 689692.116. Nukaga M., Haruta S., Tanimoto K., Kogure K., Taniguchi K., TamakiM., Sawai T. Molecular evolution of a class C beta-lactamase extendingits substrate specificity // J Biol Chem. — 1995.
— V. 270, № 11. — P.5729-5735.117. Organization W. H. WHO Global Strategy for Containment ofAntimicrobial Resistance // WHO/CDS/CSR/DRS/2001.2. — 2001.118. Ozturk H., Ozkirimli E., Ozgur A. Classification of Beta-lactamases andpenicillin binding proteins using ligand-centric network models // PLoSOne. — 2015. — V. 10, № 2. — e0117874.119. Parsley L. C., Consuegra E. J., Kakirde K. S., Land A. M., Harper W. F.,Jr., Liles M. R. Identification of diverse antimicrobial resistancedeterminants carried on bacterial, plasmid, or viral metagenomes from anactivated sludge microbial assemblage // Appl Environ Microbiol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
